Literature DB >> 3808768

Severe upper airway obstruction.

H Kilham, J Gillis, B Benjamin.   

Abstract

This article describes management of newborn and older children with severe upper airway obstruction, that is, those needing or likely to need airway support for their intact survival. These children have more to gain from optimal care, and more to lose from any error than most other children requiring admission to a pediatric intensive care unit.

Entities:  

Mesh:

Year:  1987        PMID: 3808768     DOI: 10.1016/s0031-3955(16)36177-6

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  7 in total

Review 1.  The role of radiology in the evaluation of stridor.

Authors:  T R Goodman; K McHugh
Journal:  Arch Dis Child       Date:  1999-11       Impact factor: 3.791

Review 2.  An approach to respiratory distress and central nervous system emergencies.

Authors:  N Kissoon; D Vidyasagar
Journal:  Indian J Pediatr       Date:  1991 Mar-Apr       Impact factor: 1.967

3.  Management of acute upper airway obstruction in an intensive care unit in a district general hospital.

Authors:  G H Lear; S A McKenzie; H Boralessa
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

4.  Respiratory emergencies in infants and young children.

Authors:  P S Bhui
Journal:  Can Fam Physician       Date:  1988-10       Impact factor: 3.275

5.  Streptococcal pharyngitis and epiglottitis in a newborn infant.

Authors:  A P Bos; W P Fetter; W Baerts; R A van Lingen; J F Frik; R J Roorda
Journal:  Eur J Pediatr       Date:  1992-12       Impact factor: 3.183

Review 6.  Guidelines for stabilizing the condition of the critically ill child before transfer to a tertiary care facility.

Authors:  J B Kronick; N Kissoon; T C Frewen
Journal:  CMAJ       Date:  1988-08-01       Impact factor: 8.262

7.  Diagnosis and management of supraglottitis (epiglottitis).

Authors:  Fergal Glynn; John E Fenton
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.